Literature DB >> 12631131

C-reactive protein is associated with renal function abnormalities in a non-diabetic population.

Erik M Stuveling1, Hans L Hillege, Stephan J L Bakker, Reinold O B Gans, Paul E De Jong, Dick De Zeeuw.   

Abstract

BACKGROUND: C-reactive protein (CRP) has recently been introduced in cardiovascular medicine as a predictor of myocardial infarction, stroke and peripheral artery disease in different populations. We hypothesized that elevated CRP levels are associated with renal function abnormalities.
METHODS: To test this hypothesis, we studied the relationship between CRP levels and renal function loss measured as diminished creatinine clearance in a large non-diabetic population (7317 subjects). In addition, the associations and confounding effects of established renal risk factors that could explain the association between CRP and diminished renal filtration were studied. Also, the association of CRP with early alterations in renal function, such as those evidenced by a relatively high glomerular filtration ("hyperfiltration"), was examined. CRP levels were divided in quartiles. Subjects with CRP levels within the first quartile were defined as the reference group. Diminished renal filtration and hyperfiltration were defined as a creatinine clearance below or exceeding two times the prediction interval of the age- and sex-related reference group.
RESULTS: Elevated CRP levels were positively associated with cardiovascular and renal risk factors: age, body mass index, blood pressure, serum cholesterol level, smoking, plasma glucose level and elevated urinary albumin excretion. Elevated CRP was positively associated with diminished filtration (OR 1.8; 95% CI 1.2 to 2.6). In multivariate analyses, CRP was independently associated with a diminished filtration (OR 1.9; 95% CI 1.3 to 2.9). Interestingly, CRP also was associated with hyperfiltration (highest quartile, OR 1.7; 95% CI 1.2 to 2.5). However, body mass index accounted for most of the relationship between CRP and hyperfiltration.
CONCLUSIONS: As in cardiovascular disease, CRP appears to be a risk marker for renal function loss. The mechanism of this relationship remains to be clarified. However, the association between CRP, body weight, and a relatively elevated creatinine clearance is a hypothesis-generating finding, suggesting that early inflammatory processes related to high body fat may predispose the kidney to glomerular hyperfiltration-related renal function loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631131     DOI: 10.1046/j.1523-1755.2003.00762.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  66 in total

1.  Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus.

Authors:  Roberto Hernández-Marco; Pilar Codoñer-Franch; Sara Pons Morales; Cristina Del Castillo Villaescusa; Laura Boix García; Victoria Valls Bellés
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

Review 2.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

3.  C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.

Authors:  Eitan Kugler; Eytan Cohen; Elad Goldberg; Yuval Nardi; Amos Levi; Irit Krause; Moshe Garty; Ilan Krause
Journal:  J Nephrol       Date:  2014-07-01       Impact factor: 3.902

4.  Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.

Authors:  Ali Monfared; Arsalan Salari; Ehsan Kazemnezhad; Mohammadkazem Lebadi; Masoud Khosravi; Neda Kalantar Mehrjardi; Shahrzad Rahimifar; Nazly Amini
Journal:  Int Urol Nephrol       Date:  2013-01-11       Impact factor: 2.370

5.  Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.

Authors:  Arjan J Kwakernaak; Dorien M Zelle; Stephan J L Bakker; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 10.121

6.  Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Authors:  Dena E Rifkin; Ronit Katz; Michel Chonchol; Linda F Fried; Jie Cao; Ian H de Boer; David S Siscovick; Michael G Shlipak; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2009-12-15       Impact factor: 5.992

7.  MRI Features and Site-specific Factors of Ischemic Changes in White Matter: A Retrospective Study.

Authors:  You-Ping Zhang; Na Liu; Kai-Yan Liu; Chao Pan; Xuan Cai; Shi-Qi Yang; Zhou-Ping Tang; Sha-Bei Xu
Journal:  Curr Med Sci       Date:  2018-04-30

8.  C-reactive protein exacerbates renal ischemia-reperfusion injury.

Authors:  Melissa A Pegues; Mark A McCrory; Abolfazl Zarjou; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-27

9.  Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan.

Authors:  Y-W Tsai; M-C Lu; Y-H Lin; Y-C Lee; W-C Li; J-Y Chen; S-S Chang
Journal:  Eur J Clin Nutr       Date:  2016-03-16       Impact factor: 4.016

10.  The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor
Journal:  BMC Nephrol       Date:  2010-01-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.